Medicover AB (LTS:0RPS) Beta: 1.0362 (As of Jul. 04, 2026)


LTS:0RPS Medicover AB LTS:0RPS
89 GF Score
Price kr238.00
GF Value kr233.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Beta?

Medicover AB LTS:0RPS +0.42% 89 Beta is 1.0362 as of Jul. 04, 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr233.91 (Fairly Valued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-04), Medicover AB's Beta is 1.0362.


Medicover AB  (LTS:0RPS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Medicover AB Beta Related Terms


Medicover AB Beta Historical Data

* Premium members only.

The historical data trend for Medicover AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Beta Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.31 2.24 1.20

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 1.65 1.39 1.20 0.97

LTS:0RPS vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Medicover AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Beta distribution charts can be found below:

* The bar in red indicates where Medicover AB's Beta falls into.


LTS:0RPS
89GF Score
Medicover AB LTS:0RPS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.0362 mean?
Medicover AB (LTS:0RPS) has a Beta of 1.0362 as of Jul. 04, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medicover AB and its competitors.
Is Medicover AB's Beta too high?
Medicover AB's current Beta is 1.0362. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Beta compare to HCA and THC?
Medicover AB's Beta of 1.0362 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Medicover AB and its competitors. Medicover AB's current Beta is 1.0362. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.91, compared to a current price of kr238.00 — trading 1.7% above its estimated fair value. The current Beta is 1.0362. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Beta is 1.0362 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr238.00 is trading 1.7% above its estimated GF Value™ of kr233.91. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Beta: 1.0362
  • GF Value™: kr233.91 vs. price of kr238.00 (1.7% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score

Get the complete analysis for LTS:0RPS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr238.00
Price
kr233.91
GF Value